Benjamin M Wu, MD
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 6 carriers
- Offices
- 2
Offices
2 locations · El Camino Health Medical Network LLC · Physician Services at El Camino Hospital
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
24 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A68778 · Current
Licensed to practise in California · since 1999 · expires 2027-02-28 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$224,949
Medicare paid this office $224,949 for 1,254 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 284 | $62,658 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 308 | $58,578 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $14,153 | $105 |
| New patient visit (60+ min) | 51 | $9,704 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,208 | $144 |
See all 23 services
| Return visit (30+ min) | 284 | $62,658 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 308 | $58,578 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $14,153 | $105 |
| New patient visit (60+ min) | 51 | $9,704 | $190 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $8,208 | $144 |
| Long return visit (40+ min) | 52 | $8,004 | $151 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $6,928 | $59 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 17 | $4,625 | $272 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 503 | $4,424 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,983 | $69 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 13 | $3,868 | $298 |
| Critical care, first 30-74 minutes | 11 | $3,685 | $175 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 15 | $3,502 | $233 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 207 | $2,805 | $12 |
| Programming of dual lead pacemaker system | 26 | $2,427 | $61 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 19 | $895 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $858 | $25 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $747 | $50 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $702 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $360 | $24 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 15 | $314 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 21 | $262 | $10 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 15 | $171 | $11 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
Who their Medicare patients are
1,254 Original Medicare patients in 2024. Average age 79 · Under 65 3% · 85 and older 31% · Women 47% · Also on Medicaid 18% · Health risk score 1.69. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 44% · Atrial fibrillation 39% · Heart failure 35% · Diabetes 33% · Chronic kidney disease 33% · Cancer 22% · Depression 21% · Dementia 18% · COPD 15% · Stroke 15%.
The office billed $1,100,001, Medicare allowed $301,765 and paid $224,949; for 2,665 services of 71 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,254 | 2,665 | 79 | 1.69 | $1,100,001 | $224,949 |
| 2023 | 1,056 | 2,559 | 79 | 1.60 | $1,175,583 | $217,774 |
| 2022 | 990 | 2,274 | 79 | 1.65 | $987,987 | $187,798 |
| 2021 | 890 | 2,297 | 79 | 1.61 | $1,028,868 | $201,111 |
| 2020 | 346 | 1,089 | 78 | 1.66 | $435,294 | $100,311 |
| 2019 | 318 | 1,086 | 77 | 1.53 | $392,781 | $97,535 |
| 2018 | 246 | 875 | 77 | 1.66 | $390,960 | $81,407 |
| 2017 | 269 | 912 | 77 | 1.75 | $305,770 | $77,368 |
| 2016 | 252 | 906 | 77 | 1.87 | $313,333 | $80,274 |
| 2015 | 257 | 857 | 76 | 1.73 | $277,715 | $78,766 |
| 2014 | 288 | 885 | 77 | 1.65 | $325,678 | $83,484 |
| 2013 | 260 | 806 | 76 | 1.63 | $183,741 | $67,176 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 277 | $53,127 | $190 |
| Return visit (30+ min) | 229 | $53,099 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $18,544 | $107 |
| Critical care, first 30-74 minutes | 27 | $12,969 | $188 |
| New patient visit (60+ min) | 47 | $9,269 | $197 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $8,982 | $147 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 100 | $6,171 | $60 |
| Long return visit (40+ min) | 35 | $5,355 | $153 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 220 | $5,341 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 394 | $3,406 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $3,206 | $229 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $2,638 | $220 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 161 | $2,343 | $13 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 14 | $2,300 | $164 |
| Short return visit (20+ min) | 13 | $876 | $67 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $472 | $11 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 17 | $344 | $20 |
| Blood test, clotting time | 23 | $265 | $4 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 17 | $195 | $11 |
2022: 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 313 | $64,613 | $202 |
| Return visit (30+ min) | 189 | $40,912 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $14,878 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $11,577 | $181 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 247 | $7,132 | $23 |
| New patient visit (60+ min) | 31 | $6,321 | $204 |
| Long return visit (40+ min) | 37 | $6,234 | $160 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 75 | $4,726 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 335 | $3,531 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 11 | $2,560 | $233 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,284 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 80 | $1,150 | $13 |
| Short return visit (20+ min) | 11 | $666 | $61 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $479 | $22 |
| Telephone medical discussion with physician, 5-10 minutes | 14 | $385 | $28 |
| Blood test, clotting time | 30 | $380 | $4 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 22 | $306 | $14 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $255 | $11 |
2021: 24 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 269 | $57,283 | $205 |
| Return visit (30+ min) | 214 | $46,985 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $15,370 | $95 |
| New patient visit (60+ min) | 75 | $14,918 | $199 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,859 | $179 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,181 | $220 |
| Long return visit (40+ min) | 21 | $3,706 | $176 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 50 | $3,235 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 320 | $3,192 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 130 | $3,002 | $22 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,809 | $216 |
| Programming of dual lead pacemaker system | 19 | $1,909 | $73 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 27 | $1,853 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 126 | $1,752 | $13 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $1,407 | $78 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 27 | $1,267 | $25 |
| Short return visit (20+ min) | 12 | $1,225 | $88 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 21 | $908 | $23 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 31 | $716 | $23 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 34 | $499 | $15 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $401 | $11 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 13 | $331 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 11 | $169 | $15 |
| Blood test, clotting time | 16 | $82 | $4 |
2020: 17 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 114 | $23,924 | $206 |
| Return visit (30+ min) | 149 | $21,251 | $93 |
| New patient visit (60+ min) | 60 | $10,943 | $182 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $7,656 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $6,172 | $96 |
| Telephone medical discussion with physician, 11-20 minutes | 46 | $3,517 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 42 | $2,886 | $69 |
| Injection, regadenoson, 0.1 mg | 16 | $2,886 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 42 | $2,625 | $61 |
| Programming of dual lead pacemaker system | 21 | $1,983 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 107 | $1,738 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 21 | $955 | $27 |
| External ekg recording for more than 48 hours up to 21 days | 24 | $676 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $635 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 24 | $591 | $25 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $490 | $38 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $124 | $11 |
2019: 13 services
| Return visit (30+ min) | 202 | $36,070 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 109 | $23,270 | $204 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 70 | $4,766 | $64 |
| New patient visit (45+ min) | 27 | $4,180 | $155 |
| New patient visit (60+ min) | 19 | $3,651 | $192 |
| Long return visit (40+ min) | 28 | $3,274 | $117 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,932 | $183 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 153 | $2,724 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $2,109 | $81 |
| Injection, regadenoson, 0.1 mg | 11 | $1,902 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 26 | $1,826 | $68 |
| Programming of dual lead pacemaker system | 24 | $1,809 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 14 | $695 | $25 |
2018: 10 services
| Return visit (30+ min) | 143 | $26,432 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 96 | $20,017 | $200 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $5,170 | $178 |
| Long return visit (40+ min) | 29 | $4,012 | $134 |
| New patient visit (45+ min) | 26 | $3,620 | $139 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,120 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 119 | $2,165 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $1,937 | $77 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $1,829 | $63 |
| Programming of dual lead pacemaker system | 20 | $1,417 | $47 |
2017: 12 services
| Return visit (30+ min) | 163 | $23,174 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 99 | $21,687 | $213 |
| New patient visit (45+ min) | 47 | $6,318 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $4,495 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,897 | $170 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 45 | $2,455 | $53 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 129 | $2,005 | $14 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,525 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,491 | $115 |
| Programming of dual lead pacemaker system | 23 | $1,483 | $46 |
| Long return visit (40+ min) | 11 | $1,401 | $127 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 12 | $563 | $23 |
2016: 10 services
| Return visit (30+ min) | 149 | $26,116 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 106 | $23,368 | $212 |
| New patient visit (45+ min) | 37 | $5,147 | $139 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,779 | $116 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,490 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $2,346 | $55 |
| Programming of dual lead pacemaker system | 29 | $2,132 | $46 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 119 | $2,033 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $1,947 | $75 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 11 | $497 | $22 |
2015: 15 services
| Return visit (30+ min) | 124 | $21,183 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $15,032 | $224 |
| New patient visit (45+ min) | 41 | $6,510 | $159 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $5,374 | $128 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $4,489 | $98 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $3,371 | $281 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 20 | $3,143 | $131 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 47 | $2,869 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 94 | $1,658 | $16 |
| Programming of dual lead pacemaker system | 16 | $1,347 | $52 |
| Thallium tl-201 thallous chloride, diagnostic, per millicurie | 14 | $942 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $862 | $72 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $308 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $231 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $151 | $14 |
2014: 11 services
| Return visit (30+ min) | 128 | $21,346 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 83 | $18,758 | $216 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $6,082 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $5,265 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 83 | $4,650 | $55 |
| New patient visit (45+ min) | 26 | $3,652 | $140 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 96 | $1,698 | $15 |
| Programming of dual lead pacemaker system | 17 | $1,239 | $54 |
| Electrocardiogram (ecg) 2-day continuous with report | 17 | $595 | $33 |
| Electrocardiogram (ecg) 2-day continuous | 17 | $357 | $20 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 16 | $340 | $20 |
2013: 12 services
| Return visit (30+ min) | 125 | $22,998 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $11,574 | $187 |
| New patient visit (45+ min) | 61 | $8,907 | $146 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 65 | $3,704 | $55 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,966 | $119 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 122 | $2,364 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,347 | $90 |
| Programming of dual lead pacemaker system | 13 | $1,063 | $53 |
| Electrocardiogram (ecg) 2-day continuous with report | 15 | $551 | $37 |
| Electrocardiogram (ecg) 2-day continuous | 15 | $331 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $303 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $260 | $20 |
Medicaid work
$1,835 in 2024
Medicaid paid $1,835 for 346 billed services this clinician did in 2024, up to 132 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 320 | $1,446 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 26 | $388 |
| 2024 | 346 | 2 | 132 | $1,835 |
| 2023 | 252 | 2 | 115 | $1,753 |
| 2022 | 179 | 1 | 73 | $760 |
| 2021 | 177 | 1 | 80 | $1,012 |
| 2020 | 28 | 1 | 26 | $184 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 223 | $1,186 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 29 | $567 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 179 | $760 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 177 | $1,012 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 28 | $184 |
Drugs they prescribed that Part D paid
$1,030,641
Pharmacies billed $1,030,641 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 3,572) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,725 generic and 847 brand-name prescriptions · $1,030,641 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 392 | $464,930 | $1,186 |
| Entresto | 174 | $236,718 | $1,360 |
| Jardiance | 120 | $144,488 | $1,204 |
| Repatha Sureclick | 45 | $55,764 | $1,239 |
| Xarelto | 32 | $41,771 | $1,305 |
See all 38 drugs
| Eliquis | 392 | $464,930 | $1,186 |
| Entresto | 174 | $236,718 | $1,360 |
| Jardiance | 120 | $144,488 | $1,204 |
| Repatha Sureclick | 45 | $55,764 | $1,239 |
| Xarelto | 32 | $41,771 | $1,305 |
| Farxiga | 16 | $25,915 | $1,620 |
| Metoprolol | 356 | $6,232 | $18 |
| Rosuvastatin | 207 | $4,764 | $23 |
| Atorvastatin | 278 | $3,905 | $14 |
| Carvedilol | 260 | $3,822 | $15 |
| Amiodarone | 75 | $3,547 | $47 |
| Losartan | 255 | $3,073 | $12 |
| Ranolazine Er | 12 | $2,290 | $191 |
| Hydralazine | 73 | $1,576 | $22 |
| Potassium Chloride | 103 | $1,499 | $15 |
| Amlodipine Besylate | 151 | $1,214 | $8 |
| Diltiazem 24hr Er (Xr) | 24 | $1,201 | $50 |
| Flecainide Acetate | 41 | $1,168 | $28 |
| Furosemide | 134 | $1,142 | $9 |
| Clopidogrel | 58 | $1,030 | $18 |
| Ezetimibe | 37 | $1,028 | $28 |
| Bumetanide | 39 | $837 | $21 |
| Isosorbide Mononitrate Er | 46 | $823 | $18 |
| Lisinopril | 73 | $767 | $11 |
| Diltiazem 24hr Er (Cd) | 25 | $758 | $30 |
| Losartan-Hydrochlorothiazide | 60 | $738 | $12 |
| Torsemide | 30 | $649 | $22 |
| Hydrochlorothiazide | 96 | $634 | $7 |
| Nifedipine Er | 14 | $508 | $36 |
| Metoprolol | 50 | $447 | $9 |
| Benazepril | 13 | $387 | $30 |
| Olmesartan Medoxomil | 18 | $334 | $19 |
| Spironolactone | 40 | $322 | $8 |
| Klor-Con 10 | 13 | $211 | $16 |
| Nitroglycerin | 18 | $183 | $10 |
| Sotalol | 13 | $125 | $10 |
| Triamterene-Hydrochlorothiazid | 11 | $103 | $9 |
| Lisinopril-Hydrochlorothiazide | 12 | $73 | $6 |
Year by year
| 2024 | 3,572 | 497 | 0% (0) | 24% | $1,030,641 |
| 2023 | 3,030 | 440 | 0% (0) | 21% | $831,115 |
| 2022 | 2,607 | 401 | 0% (0) | 21% | $620,698 |
| 2021 | 2,086 | 383 | None | 24% | $458,042 |
| 2020 | 1,818 | 341 | 0% (0) | 23% | $335,903 |
| 2019 | 2,001 | 338 | None | 26% | $297,388 |
| 2018 | 1,850 | 282 | 0% (0) | 22% | $229,970 |
| 2017 | 2,207 | 266 | 0% (0) | 26% | $196,759 |
| 2016 | 1,933 | 236 | None | 22% | $119,712 |
| 2015 | 1,552 | 198 | 0% (0) | 19% | $71,423 |
| 2014 | 2,025 | 240 | None | 19% | $80,075 |
| 2013 | 2,114 | 257 | None | 17% | $62,338 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Eliquis | 385 | $463,651 | $1,204 |
| Entresto | 114 | $167,362 | $1,468 |
| Jardiance | 47 | $74,648 | $1,588 |
| Xarelto | 24 | $33,191 | $1,383 |
| Farxiga | 13 | $12,531 | $964 |
| Metoprolol | 350 | $8,984 | $26 |
| Atorvastatin | 240 | $5,313 | $22 |
| Potassium Chloride | 117 | $5,025 | $43 |
| Ranolazine Er | 15 | $4,621 | $308 |
| Rosuvastatin | 163 | $4,037 | $25 |
| Amiodarone | 77 | $3,953 | $51 |
| Flecainide Acetate | 31 | $3,099 | $100 |
| Bumetanide | 36 | $2,860 | $79 |
| Carvedilol | 185 | $2,754 | $15 |
| Losartan | 190 | $2,716 | $14 |
| Ezetimibe | 31 | $2,382 | $77 |
| Hydralazine | 73 | $2,035 | $28 |
| Diltiazem 24hr Er (Cd) | 28 | $1,946 | $70 |
| Diltiazem 24hr Er (Xr) | 34 | $1,799 | $53 |
| Clopidogrel | 62 | $1,471 | $24 |
| Torsemide | 37 | $1,451 | $39 |
| Sotalol | 13 | $1,129 | $87 |
| Lisinopril | 82 | $1,124 | $14 |
| Amlodipine Besylate | 123 | $1,060 | $9 |
| Furosemide | 144 | $1,056 | $7 |
| Isosorbide Mononitrate Er | 38 | $904 | $24 |
| Metoprolol | 42 | $515 | $12 |
| Hydrochlorothiazide | 72 | $445 | $6 |
| Nifedipine Er | 14 | $440 | $31 |
| Olmesartan Medoxomil | 14 | $319 | $23 |
| Nitroglycerin | 18 | $308 | $17 |
| Losartan-Hydrochlorothiazide | 31 | $283 | $9 |
| Spironolactone | 18 | $224 | $12 |
2022: 32 drugs
| Eliquis | 374 | $421,568 | $1,127 |
| Entresto | 62 | $72,530 | $1,170 |
| Xarelto | 39 | $51,279 | $1,315 |
| Ethacrynic Acid | 12 | $12,192 | $1,016 |
| Metoprolol | 304 | $7,692 | $25 |
| Rosuvastatin | 134 | $6,524 | $49 |
| Potassium Chloride | 71 | $4,114 | $58 |
| Ranolazine Er | 23 | $3,627 | $158 |
| Atorvastatin | 166 | $3,075 | $19 |
| Amiodarone | 68 | $3,045 | $45 |
| Carvedilol | 168 | $2,387 | $14 |
| Flecainide Acetate | 27 | $2,355 | $87 |
| Losartan | 149 | $2,294 | $15 |
| Hydralazine | 62 | $1,995 | $32 |
| Diltiazem 24hr Er (Cd) | 40 | $1,812 | $45 |
| Bumetanide | 22 | $1,706 | $78 |
| Clopidogrel | 58 | $1,318 | $23 |
| Amlodipine Besylate | 155 | $1,302 | $8 |
| Furosemide | 140 | $1,213 | $9 |
| Dilt-Xr | 24 | $1,107 | $46 |
| Diltiazem 24hr Er (Xr) | 17 | $1,093 | $64 |
| Isosorbide Mononitrate Er | 40 | $1,030 | $26 |
| Torsemide | 29 | $788 | $27 |
| Losartan-Hydrochlorothiazide | 24 | $634 | $26 |
| Metoprolol | 64 | $614 | $10 |
| Lisinopril | 69 | $552 | $8 |
| Spironolactone | 29 | $412 | $14 |
| Hydrochlorothiazide | 55 | $405 | $7 |
| Nitroglycerin | 22 | $344 | $16 |
| Simvastatin | 17 | $332 | $20 |
| Atenolol | 11 | $147 | $13 |
| Olmesartan Medoxomil | 11 | $134 | $12 |
2021: 27 drugs
| Eliquis | 313 | $338,830 | $1,083 |
| Xarelto | 42 | $45,060 | $1,073 |
| Entresto | 26 | $18,608 | $716 |
| Metoprolol | 275 | $7,459 | $27 |
| Potassium Chloride | 72 | $3,940 | $55 |
| Flecainide Acetate | 16 | $2,566 | $160 |
| Atorvastatin | 121 | $1,967 | $16 |
| Carvedilol | 153 | $1,943 | $13 |
| Losartan | 113 | $1,669 | $15 |
| Amiodarone | 47 | $1,516 | $32 |
| Propafenone | 12 | $1,512 | $126 |
| Dilt-Xr | 36 | $1,366 | $38 |
| Diltiazem 24hr Er (Cd) | 22 | $1,310 | $60 |
| Furosemide | 151 | $1,274 | $8 |
| Rosuvastatin | 40 | $1,175 | $29 |
| Hydralazine | 26 | $1,099 | $42 |
| Clopidogrel | 61 | $1,034 | $17 |
| Diltiazem 24hr Er | 15 | $856 | $57 |
| Amlodipine Besylate | 117 | $794 | $7 |
| Metoprolol | 67 | $612 | $9 |
| Lisinopril | 73 | $611 | $8 |
| Isosorbide Mononitrate Er | 30 | $575 | $19 |
| Spironolactone | 33 | $344 | $10 |
| Pravastatin | 13 | $233 | $18 |
| Simvastatin | 21 | $215 | $10 |
| Hydrochlorothiazide | 26 | $135 | $5 |
| Atenolol | 11 | $106 | $10 |
2020: 25 drugs
| Eliquis | 236 | $240,678 | $1,020 |
| Xarelto | 49 | $45,642 | $931 |
| Metoprolol | 297 | $8,958 | $30 |
| Potassium Chloride | 85 | $3,969 | $47 |
| Flecainide Acetate | 14 | $1,495 | $107 |
| Atorvastatin | 79 | $1,485 | $19 |
| Furosemide | 145 | $1,478 | $10 |
| Carvedilol | 137 | $1,465 | $11 |
| Propafenone | 12 | $1,287 | $107 |
| Amiodarone | 40 | $1,123 | $28 |
| Losartan | 85 | $1,105 | $13 |
| Hydralazine | 28 | $974 | $35 |
| Diltiazem 24hr Er | 15 | $907 | $60 |
| Lisinopril | 76 | $805 | $11 |
| Cartia Xt | 14 | $782 | $56 |
| Clopidogrel | 40 | $776 | $19 |
| Amlodipine Besylate | 90 | $735 | $8 |
| Isosorbide Mononitrate Er | 25 | $679 | $27 |
| Metoprolol | 64 | $650 | $10 |
| Dilt-Xr | 11 | $592 | $54 |
| Rosuvastatin | 21 | $552 | $26 |
| Spironolactone | 34 | $388 | $11 |
| Atenolol | 20 | $132 | $7 |
| Hydrochlorothiazide | 13 | $112 | $9 |
| Simvastatin | 13 | $81 | $6 |
2019: 29 drugs
| Eliquis | 294 | $183,600 | $624 |
| Xarelto | 68 | $49,000 | $721 |
| Metoprolol | 265 | $11,100 | $42 |
| Carvedilol | 158 | $3,409 | $22 |
| Potassium Chloride | 66 | $3,222 | $49 |
| Atorvastatin | 80 | $2,117 | $26 |
| Furosemide | 163 | $1,955 | $12 |
| Hydralazine | 40 | $1,936 | $48 |
| Cartia Xt | 21 | $1,878 | $89 |
| Flecainide Acetate | 17 | $1,732 | $102 |
| Rosuvastatin | 12 | $1,518 | $127 |
| Amlodipine Besylate | 110 | $1,424 | $13 |
| Metoprolol | 106 | $1,231 | $12 |
| Losartan | 82 | $1,180 | $14 |
| Lisinopril | 69 | $1,115 | $16 |
| Clopidogrel | 49 | $1,115 | $23 |
| Amiodarone | 52 | $1,077 | $21 |
| Propafenone | 12 | $1,009 | $84 |
| Bumetanide | 11 | $929 | $84 |
| Diltiazem 24hr Er (Cd) | 15 | $907 | $60 |
| Dilt-Xr | 11 | $835 | $76 |
| Isosorbide Mononitrate Er | 23 | $691 | $30 |
| Simvastatin | 30 | $468 | $16 |
| Sotalol | 18 | $383 | $21 |
| Nitroglycerin | 18 | $371 | $21 |
| Warfarin | 13 | $331 | $25 |
| Spironolactone | 28 | $232 | $8 |
| Losartan-Hydrochlorothiazide | 11 | $162 | $15 |
| Hydrochlorothiazide | 19 | $149 | $8 |
2018: 27 drugs
| Eliquis | 211 | $121,233 | $575 |
| Xarelto | 60 | $39,982 | $666 |
| Ranexa | 34 | $18,534 | $545 |
| Metoprolol | 199 | $10,121 | $51 |
| Flecainide Acetate | 35 | $3,332 | $95 |
| Carvedilol | 139 | $2,439 | $18 |
| Atorvastatin | 73 | $2,179 | $30 |
| Hydralazine | 38 | $2,019 | $53 |
| Cartia Xt | 25 | $2,014 | $81 |
| Clopidogrel | 71 | $1,795 | $25 |
| Furosemide | 166 | $1,601 | $10 |
| Amlodipine Besylate | 88 | $1,387 | $16 |
| Dilt-Xr | 21 | $1,196 | $57 |
| Potassium Chloride | 42 | $1,144 | $27 |
| Metoprolol | 99 | $1,100 | $11 |
| Losartan | 72 | $884 | $12 |
| Amiodarone | 62 | $818 | $13 |
| Isosorbide Mononitrate Er | 32 | $780 | $24 |
| Lisinopril | 62 | $745 | $12 |
| Sotalol | 31 | $742 | $24 |
| Nitroglycerin | 21 | $676 | $32 |
| Simvastatin | 29 | $530 | $18 |
| Diltiazem 24hr Er (Cd) | 14 | $480 | $34 |
| Spironolactone | 55 | $465 | $8 |
| Pravastatin | 11 | $286 | $26 |
| Benazepril | 13 | $241 | $19 |
| Hydrochlorothiazide | 13 | $103 | $8 |
2017: 32 drugs
| Eliquis | 224 | $100,244 | $448 |
| Xarelto | 56 | $35,776 | $639 |
| Ranexa | 47 | $18,214 | $388 |
| Metoprolol | 247 | $7,407 | $30 |
| Flecainide Acetate | 34 | $2,643 | $78 |
| Amiodarone | 114 | $2,081 | $18 |
| Atorvastatin | 89 | $1,812 | $20 |
| Potassium Chloride | 56 | $1,778 | $32 |
| Clopidogrel | 90 | $1,694 | $19 |
| Carvedilol | 148 | $1,378 | $9 |
| Hydralazine | 65 | $1,327 | $20 |
| Dilt-Xr | 39 | $974 | $25 |
| Diltiazem 24hr Er | 21 | $897 | $43 |
| Metoprolol | 118 | $861 | $7 |
| Isosorbide Mononitrate Er | 37 | $846 | $23 |
| Furosemide | 145 | $816 | $6 |
| Cartia Xt | 23 | $812 | $35 |
| Valsartan | 24 | $691 | $29 |
| Sotalol | 18 | $669 | $37 |
| Verapamil Er | 13 | $577 | $44 |
| Digox | 15 | $520 | $35 |
| Lisinopril | 76 | $478 | $6 |
| Amlodipine Besylate | 93 | $440 | $5 |
| Warfarin | 29 | $425 | $15 |
| Losartan | 58 | $348 | $6 |
| Nitroglycerin | 20 | $328 | $16 |
| Labetalol | 13 | $282 | $22 |
| Pravastatin | 11 | $255 | $23 |
| Spironolactone | 55 | $250 | $5 |
| Simvastatin | 35 | $235 | $7 |
| Hydrochlorothiazide | 37 | $186 | $5 |
| Lisinopril-Hydrochlorothiazide | 15 | $93 | $6 |
2016: 34 drugs
| Eliquis | 103 | $43,860 | $426 |
| Xarelto | 55 | $27,034 | $492 |
| Ranexa | 29 | $10,719 | $370 |
| Pradaxa | 21 | $9,318 | $444 |
| Metoprolol | 287 | $6,507 | $23 |
| Clopidogrel | 117 | $2,288 | $20 |
| Diltiazem 24hr Er | 33 | $1,676 | $51 |
| Atorvastatin | 94 | $1,418 | $15 |
| Carvedilol | 127 | $1,145 | $9 |
| Isosorbide Mononitrate Er | 64 | $1,089 | $17 |
| Amiodarone | 61 | $1,073 | $18 |
| Potassium Chloride | 40 | $987 | $25 |
| Furosemide | 124 | $754 | $6 |
| Sotalol | 17 | $721 | $42 |
| Metoprolol | 89 | $714 | $8 |
| Hydralazine | 35 | $699 | $20 |
| Lisinopril | 111 | $646 | $6 |
| Flecainide Acetate | 26 | $621 | $24 |
| Dilt-Xr | 24 | $616 | $26 |
| Digoxin | 13 | $554 | $43 |
| Verapamil Er | 12 | $458 | $38 |
| Labetalol | 20 | $446 | $22 |
| Warfarin | 24 | $414 | $17 |
| Propafenone | 12 | $373 | $31 |
| Amlodipine Besylate | 83 | $367 | $4 |
| Losartan | 47 | $320 | $7 |
| Digox | 12 | $263 | $22 |
| Lisinopril-Hydrochlorothiazide | 33 | $195 | $6 |
| Hydrochlorothiazide | 22 | $147 | $7 |
| Simvastatin | 24 | $141 | $6 |
| Atenolol | 16 | $87 | $5 |
| Spironolactone | 14 | $74 | $5 |
| Klor-Con 10 | 11 | $72 | $7 |
| Losartan-Hydrochlorothiazide | 11 | $38 | $3 |
2015: 30 drugs
| Ranexa | 32 | $16,372 | $512 |
| Eliquis | 35 | $11,516 | $329 |
| Xarelto | 22 | $8,590 | $390 |
| Pradaxa | 13 | $6,045 | $465 |
| Metoprolol | 259 | $5,604 | $22 |
| Clopidogrel | 146 | $2,095 | $14 |
| Carvedilol | 148 | $1,356 | $9 |
| Isosorbide Mononitrate Er | 49 | $1,144 | $23 |
| Flecainide Acetate | 26 | $1,033 | $40 |
| Potassium Chloride | 41 | $985 | $24 |
| Diltiazem 24hr Er | 20 | $770 | $38 |
| Atorvastatin | 59 | $755 | $13 |
| Dilt-Xr | 27 | $695 | $26 |
| Labetalol | 27 | $691 | $26 |
| Metoprolol | 93 | $587 | $6 |
| Diltiazem Er | 21 | $507 | $24 |
| Lisinopril | 70 | $488 | $7 |
| Furosemide | 79 | $449 | $6 |
| Propafenone | 22 | $376 | $17 |
| Verapamil Er | 13 | $360 | $28 |
| Sotalol | 23 | $359 | $16 |
| Amlodipine Besylate | 79 | $357 | $5 |
| Hydralazine | 13 | $312 | $24 |
| Amiodarone | 36 | $311 | $9 |
| Digox | 12 | $306 | $26 |
| Simvastatin | 32 | $197 | $6 |
| Losartan | 22 | $178 | $8 |
| Warfarin | 11 | $174 | $16 |
| Hydrochlorothiazide | 15 | $76 | $5 |
| Acebutolol | 11 | $51 | $5 |
2014: 36 drugs
| Ranexa | 45 | $18,917 | $420 |
| Eliquis | 25 | $8,914 | $357 |
| Metoprolol | 252 | $8,557 | $34 |
| Effient | 19 | $6,654 | $350 |
| Pradaxa | 15 | $6,038 | $403 |
| Carvedilol | 262 | $2,596 | $10 |
| Clopidogrel | 99 | $2,426 | $25 |
| Diovan | 15 | $2,037 | $136 |
| Isosorbide Mononitrate Er | 82 | $1,593 | $19 |
| Diltiazem Er | 50 | $1,538 | $31 |
| Atorvastatin | 82 | $1,331 | $16 |
| Potassium Chloride | 56 | $1,186 | $21 |
| Labetalol | 41 | $1,002 | $24 |
| Diltiazem 24hr Er | 27 | $976 | $36 |
| Metoprolol | 113 | $921 | $8 |
| Hydralazine | 39 | $784 | $20 |
| Digox | 22 | $769 | $35 |
| Flecainide Acetate | 26 | $688 | $26 |
| Lisinopril | 91 | $587 | $6 |
| Furosemide | 94 | $516 | $5 |
| Amiodarone | 41 | $506 | $12 |
| Sotalol | 23 | $485 | $21 |
| Amlodipine Besylate | 108 | $443 | $4 |
| Dilt-Xr | 18 | $439 | $24 |
| Propafenone | 20 | $402 | $20 |
| Simvastatin | 44 | $329 | $7 |
| Klor-Con M10 | 11 | $321 | $29 |
| Pantoprazole | 18 | $270 | $15 |
| Warfarin | 30 | $268 | $9 |
| Pravastatin | 16 | $249 | $16 |
| Losartan | 27 | $203 | $8 |
| Nitrostat | 13 | $164 | $13 |
| Losartan-Hydrochlorothiazide | 15 | $156 | $10 |
| Spironolactone | 20 | $96 | $5 |
| Hydrochlorothiazide | 18 | $91 | $5 |
| Lisinopril-Hydrochlorothiazide | 16 | $48 | $3 |
2013: 36 drugs
| Ranexa | 36 | $12,543 | $348 |
| Metoprolol | 269 | $8,856 | $33 |
| Effient | 15 | $4,905 | $327 |
| Diovan | 38 | $4,331 | $114 |
| Pradaxa | 14 | $3,829 | $274 |
| Clopidogrel | 142 | $3,454 | $24 |
| Carvedilol | 315 | $3,347 | $11 |
| Atorvastatin | 83 | $2,247 | $27 |
| Isosorbide Mononitrate Er | 71 | $1,326 | $19 |
| Hydralazine | 60 | $1,200 | $20 |
| Diltiazem Er | 37 | $1,081 | $29 |
| Amiodarone | 47 | $862 | $18 |
| Lisinopril | 148 | $807 | $5 |
| Warfarin | 63 | $748 | $12 |
| Diltiazem 24hr Er | 32 | $664 | $21 |
| Cartia Xt | 15 | $624 | $42 |
| Sotalol | 20 | $583 | $29 |
| Potassium Chloride | 25 | $581 | $23 |
| Metoprolol | 76 | $566 | $7 |
| Labetalol | 20 | $505 | $25 |
| Furosemide | 89 | $464 | $5 |
| Flecainide Acetate | 23 | $458 | $20 |
| Amlodipine Besylate | 99 | $454 | $5 |
| Simvastatin | 52 | $444 | $9 |
| Dilt-Xr | 17 | $404 | $24 |
| Pantoprazole | 19 | $390 | $21 |
| Verapamil Er | 15 | $380 | $25 |
| Digox | 19 | $377 | $20 |
| Losartan | 33 | $323 | $10 |
| Hydrochlorothiazide | 46 | $265 | $6 |
| Fosinopril | 11 | $164 | $15 |
| Lisinopril-Hydrochlorothiazide | 26 | $156 | $6 |
| Losartan-Hydrochlorothiazide | 16 | $147 | $9 |
| Nitrostat | 13 | $144 | $11 |
| Pravastatin | 11 | $129 | $12 |
| Spironolactone | 14 | $125 | $9 |
Money from drug and device companies
$846 in 2025
| 2025 | 11 | 24 | None | $846 |
| 2024 | 8 | 9 | None | $294 |
| 2023 | 3 | 5 | None | $93 |
| 2022 | 6 | 8 | None | $409 |
| 2021 | 5 | 6 | None | $207 |
| 2020 | 3 | 6 | None | $164 |
| 2019 | 5 | 21 | None | $454 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Aurora Ev-Icd Mri Surescan | $286 | 5 payments
|
| Biosense Webster | Carto 3 | $147 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $120 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $60 | 3 payments
|
| Pfizer | Eliquis | $51 | 2 payments
|
| Amgen | Repatha | $46 | 2 payments
|
See all 23 published payments
| Amgen | Meals · 2025-12-17 | Repatha | $15 |
| Novartis Pharmaceuticals | Meals · 2025-12-15 | Leqvio | $25 |
| Biosense Webster | Meals · 2025-12-12 | Carto 3 | $147 |
| Medtronic | Meals · 2025-12-12 | Aurora Ev-Icd Mri Surescan | $113 |
| Abbott Laboratories | Meals · 2025-11-11 | Amplatzer Amulet | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-05 | Eliquis | $25 |
| Novartis Pharmaceuticals | Meals · 2025-11-04 | Leqvio | $30 |
| Medtronic | Meals · 2025-10-14 | Aurora Ev-Icd Mri Surescan | $58 |
| Amgen | Meals · 2025-10-07 | Repatha | $31 |
| Medtronic | Meals · 2025-10-02 | Aurora Ev-Icd Mri Surescan | $9 |
| Medtronic | Meals · 2025-10-01 | Omniasecure Mri Surescan | $82 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-23 | Jardiance | $17 |
| Octapharma USA | Meals · 2025-09-10 | Fibryga | $17 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-05 | Eliquis | $19 |
| Heartflow | Meals · 2025-08-05 | Ffrct | $40 |
| Novartis Pharmaceuticals | Meals · 2025-07-29 | Leqvio | $30 |
| Pfizer | Meals · 2025-06-17 | Eliquis | $24 |
| Novartis Pharmaceuticals | Meals · 2025-05-20 | Leqvio | $35 |
| Medtronic | Meals · 2025-04-22 | Symplicity G3 | $23 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-14 | Jardiance | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-14 | Jardiance | $19 |
| Boston Scientific | Meals · 2025-01-07 | Watchman Flx | $13 |
| Pfizer | Meals · 2025-01-06 | Eliquis | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $294
| Penumbra | Penumbra System | $123 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $40 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $28 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $26 | 1 payment
|
| Alnylam Pharmaceuticals | Onpattro | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $17 | 1 payment
|
| Heartflow | Ffrct | $17 | 1 payment
|
2023: $93
| Amgen | Repatha | $39 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $33 | 2 payments
|
| Novartis Pharmaceuticals | Leqvio | $21 | 1 payment
|
2022: $409
| Abbott Laboratories | Ensite Precision | $185 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $141 | 2 payments
|
| Amgen | Repatha | $30 | 2 payments
|
| Esperion Therapeutics | Nexletol | $21 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $16 | 1 payment
|
| Novo Nordisk | Ozempic | $16 | 1 payment
|
2021: $207
| Novo Nordisk | Ozempic | $131 | 2 payments
|
| Esperion Therapeutics | Nexletol | $29 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $17 | 1 payment
|
| Amgen | Repatha | $13 | 1 payment
|
2020: $164
| Bardy Diagnostics | Carnation Ambulatory Monitor | $122 | 4 payments
|
| Astellas Pharma US | Lexiscan | $23 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $19 | 1 payment
|
2019: $454
| Philips Electronics North America | Igt D Coronary | $150 | 1 payment
|
| Biotronik | None | $144 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $120 | 17 payments
|
| Astellas Pharma US | Lexiscan | $21 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1740382381
- Licence
- CA A68778California A68778: Current · expires 2027-02-28
- Trained
- Saint Louis University School of Medicine, 1996
- Group
- El Camino Health Medical Network LLC · Physician Services at El Camino Hospital
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 625 Lincoln Ave, San Jose, CA, 95126
- NPI first listed
- 2006-09-03
- NPI last updated
- 2020-12-04
- NPI record certified
- 2020-12-04
This is when the NPI record was last certified, not a medical board exam.